Merck Current Ratio 2006-2018 | MRK

Current and historical current ratio for Merck (MRK) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Merck current ratio for the three months ending September 30, 2018 was 1.44.
Merck Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $26.84B $18.59B 1.44
2018-06-30 $24.06B $18.13B 1.33
2018-03-31 $24.09B $16.96B 1.42
2017-12-31 $24.77B $18.61B 1.33
2017-09-30 $27.92B $19.47B 1.43
2017-06-30 $28.17B $18.76B 1.50
2017-03-31 $31.53B $19.82B 1.59
2016-12-31 $30.61B $17.20B 1.78
2016-09-30 $29.44B $15.56B 1.89
2016-06-30 $27.93B $14.92B 1.87
2016-03-31 $28.77B $17.57B 1.64
2015-12-31 $29.75B $19.20B 1.55
2015-09-30 $28.57B $17.58B 1.63
2015-06-30 $28.32B $17.51B 1.62
2015-03-31 $32.93B $20.44B 1.61
2014-12-31 $32.61B $18.40B 1.77
2014-09-30 $34.72B $25.93B 1.34
2014-06-30 $33.59B $17.93B 1.87
2014-03-31 $41.24B $22.47B 1.84
2013-12-31 $35.69B $17.87B 2.00
2013-09-30 $37.77B $18.22B 2.07
2013-06-30 $37.00B $18.40B 2.01
2013-03-31 $35.24B $18.80B 1.87
2012-12-31 $34.86B $18.35B 1.90
2012-09-30 $36.23B $15.58B 2.33
2012-06-30 $35.64B $16.91B 2.11
2012-03-31 $34.34B $16.58B 2.07
2011-12-31 $33.18B $16.25B 2.04
2011-09-30 $34.11B $16.59B 2.06
2011-06-30 $32.37B $15.76B 2.05
2011-03-31 $31.02B $15.66B 1.98
2010-12-31 $29.06B $15.64B 1.86
2010-09-30 $27.76B $17.32B 1.60
2010-06-30 $26.25B $15.42B 1.70
2010-03-31 $28.25B $16.46B 1.72
2009-12-31 $28.43B $15.64B 1.82
2009-09-30 $29.67B $8.03B 3.70
2009-06-30 $29.23B $11.51B 2.54
2009-03-31 $26.19B $13.42B 1.95
2008-12-31 $19.11B $14.32B 1.34
2008-09-30 $19.42B $14.43B 1.35
2008-06-30 $17.59B $9.72B 1.81
2008-03-31 $17.05B $9.80B 1.74
2007-12-31 $15.05B $12.26B 1.23
2007-09-30 $14.16B $10.51B 1.35
2007-06-30 $12.44B $10.28B 1.21
2007-03-31 $11.74B $7.86B 1.49
2006-12-31 $15.23B $12.72B 1.20
2006-09-30 $15.22B $11.15B 1.37
2006-06-30 $15.89B $10.50B 1.51
2006-03-31 $18.01B $11.30B 1.59
2005-12-31 $21.05B $13.24B 1.59
2005-09-30 $20.07B $12.16B 1.65
2005-06-30 $19.13B $11.19B 1.71
2005-03-31 $15.76B $10.90B 1.45
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $207.903B $40.122B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $393.045B 18.43
Pfizer (PFE) United States $261.986B 14.77
Novartis AG (NVS) Switzerland $201.478B 17.27
AbbVie (ABBV) United States $132.627B 11.77
Eli Lilly (LLY) United States $121.292B 21.32
Sanofi (SNY) France $111.158B 13.76
Novo Nordisk (NVO) Denmark $110.447B 17.94
AstraZeneca (AZN) United Kingdom $97.922B 12.16
GlaxoSmithKline (GSK) United Kingdom $92.650B 12.45
Bristol-Myers Squibb (BMY) United States $85.576B 14.09